Showing results (251-260 of 293) with videos related to

Sort By:
Pageof 30
Science Immunology|February 9, 2024
Mucosal and systemic immune correlates of viral control after SARS-CoV-2 infection challenge in seronegative adultsHelen R Wagstaffe, Ryan S Thwaites, Arnold Reynaldi, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|August 30, 2024
How to develop a controlled human infection model for Clostridioides difficileAnnefleur D O Hensen, Maria J G T Vehreschild, Dale N Gerding, et al.
Blood|September 13, 2011
A CCR4 antagonist combined with vaccines induces antigen-specific CD8+ T cells and tumor immunity against self antigensHelene Pere, Yves Montier, Jagadeesh Bayry, et al.
Blood|June 17, 2016
CD38 expression and complement inhibitors affect response and resistance to daratumumab therapy in myelomaInger S Nijhof, Tineke Casneuf, Jeroen van Velzen, et al.
Cell Genomics|December 5, 2022
Single-cell genome-wide association reveals that a nonsynonymous variant in ERAP1 confers increased susceptibility to influenza virusBenjamin H Schott, Liuyang Wang, Xinyu Zhu, et al.
Biologicals : Journal of the International Association of Biological Standardization|February 10, 2024
Fourth Controlled Human Infection Model (CHIM) meeting, CHIM regulatory issues, May 24, 2023Marco Cavaleri, David Kaslow, Eric Boateng, et al.
American Journal of Respiratory and Critical Care Medicine|July 13, 2021
Innate-like Gene Expression of Lung-Resident Memory CD8+ T Cells during Experimental Human Influenza: A Clinical StudySuzanna Paterson, Satwik Kar, Seng Kuong Ung, et al.
Npj Viruses|June 20, 2025
Longitudinal kinetics of the viral infection biomarker 3'-deoxy-3',4'-didehydro-cytidine in SARS-CoV-2, influenza A virus and RSV human challenge modelsRavi Mehta, Elena Chekmeneva, Stephanie Ascough, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 22, 2022
Epcoritamab, a Novel, Subcutaneous CD3xCD20 Bispecific T-Cell-Engaging Antibody, in Relapsed or Refractory Large B-Cell Lymphoma: Dose Expansion in a Phase I/II TrialCatherine Thieblemont, Tycel Phillips, Herve Ghesquieres, et al.
Leukemia|May 28, 2020
Deep immune profiling of patients treated with lenalidomide and dexamethasone with or without daratumumabTineke Casneuf, Homer C Adams, Niels W C J van de Donk, et al.
Pageof 30